Cargando…
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
PURPOSE: The aim of this study was to determine the clinical and molecular characteristics of 2,079 patients who underwent hereditary cancer multigene panel testing. METHODS: Panels included comprehensive analysis of 14–22 cancer susceptibility genes (BRCA1 and BRCA2 not included), depending on the...
Autores principales: | LaDuca, Holly, Stuenkel, A J, Dolinsky, Jill S., Keiles, Steven, Tandy, Stephany, Pesaran, Tina, Chen, Elaine, Gau, Chia-Ling, Palmaer, Erika, Shoaepour, Kamelia, Shah, Divya, Speare, Virginia, Gandomi, Stephanie, Chao, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225457/ https://www.ncbi.nlm.nih.gov/pubmed/24763289 http://dx.doi.org/10.1038/gim.2014.40 |
Ejemplares similares
-
Diagnosing hereditary cancer predisposition in men with prostate cancer
por: Pritzlaff, Mary, et al.
Publicado: (2020) -
Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022) -
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018) -
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020) -
Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)